Cargando…
Improved gene delivery to human saphenous vein cells and tissue using a peptide-modified adenoviral vector
The establishment of efficient gene delivery to target human tissue is a major obstacle for transition of gene therapy from the pre-clinical phases to the clinic. The poor long-term patency rates for coronary artery bypass grafting (CABG) is a major clinical problem that lacks an effective and prove...
Autores principales: | Work, Lorraine M, Reynolds, Paul N, Baker, Andrew H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC524365/ https://www.ncbi.nlm.nih.gov/pubmed/15473900 http://dx.doi.org/10.1186/1479-0556-2-14 |
Ejemplares similares
-
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
por: Coughlan, Lynda, et al.
Publicado: (2010) -
Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy
por: Tessarollo, Nayara Gusmão, et al.
Publicado: (2021) -
Bioresorbable vascular scaffolds in saphenous vein grafts (data from OCTOPUS registry)
por: Roleder, Tomasz, et al.
Publicado: (2015) -
Neovascularization of saphenous veins
por: Mouton, Wolfgang, et al.
Publicado: (2019) -
Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates
por: Takahashi, Marie-Noëlle, et al.
Publicado: (2010)